powered by
Center for Curriculum and Transfer Articulation
Pharmacology and Medication Administration II
Course: NUR187

First Term: 2008 Summer I
 Lecture   1.5 Credit(s)   1.5 Period(s)   1.5 Load  
Subject Type: Occupational
Load Formula: S


Description: Overview of selected drug classifications and categories. Emphasis on principles of drug metabolism and effects, interactions and adverse reactions, and nursing implications for safe practice. Requires application of previous knowledge of physical, biological, and social sciences



MCCCD Official Course Competencies
1. Identify selected prototypes within drug classifications and/or categories affecting specific body systems. (I-XI)
2. Explain the pharmacokinetics and pharmacodynamics for these drug classifications and/or categories. (I-XI)
3. Explain drug effects for the selected prototypes for these drug classifications and/or categories. (I-XI)
4. Describe the nursing considerations for the safe administration of drugs in these classifications and/or categories. (I-XI)
MCCCD Official Course Competencies must be coordinated with the content outline so that each major point in the outline serves one or more competencies. MCCCD faculty retains authority in determining the pedagogical approach, methodology, content sequencing, and assessment metrics for student work. Please see individual course syllabi for additional information, including specific course requirements.
 
MCCCD Official Course Outline
I. Pharmacologic principles of drug classification
   A. Pharmacokinetics
   B. Pharmacodynamics
   C. Contraindications and precautions
   D. Adverse effects
   E. Nursing considerations
   F. Lifespan considerations
II. Drugs affecting the gastrointestinal system
   A. Antacids
   B. Histamine H2 antagonists
   C. Proton pump inhibitors
   D. Gastrointestinal stimulants
   E. Digestive enzymes
   F. Antiflatulents
   G. Antidiarrheals
   H. Laxatives
   I. Emetics
   J. Adsorbent
   K. Antiemetics
III. Drugs affecting the central nervous system
   A. Analgesic agents
   B. General and local anesthetics
   C. Central nervous system depressants
   D. Antiepileptic/anticonvulsant agents
   E. Antiparkinsonian agents
   F. Antimyasthenic agents
   G. Psychotherapeutic agents
   H. Central nervous system stimulant agents
IV. Drugs affecting the autonomic nervous system
   A. Sympathetic nervous system drugs
   B. Parasympathetic nervous system drugs
V. Drugs affecting the cardiovascular and renal systems
   A. Antihypertensives
   B. Anti-congestive heart failure (CHF) agents
   C. Antianginal agents
   D. Antilipidemic agents
   E. Coagulation modifier agents
   F. Electrolytes
VI. Drugs affecting the endocrine system
   A. Antidiabetic and hypoglycemic agents
   B. Thyroid and antithyroid agents
   C. Parathyroid agents
   D. Adrenal agents
   E. Pituitary agents
   F. Female health agents
   G. Male health agents
VII. Drugs affecting the respiratory system
   A. Antihistamines
   B. Decongestants
   C. Antitussives
   D. Expectorants
   E. Bronchodilators
   F. Anti-inflammatory
   G. Mucolytics
   H. Herbs/supplements
VIII. Anti-infective agents
   A. Antibiotics
   B. Antiviral
   C. Antitubercular
   D. Anti-HIV
   E. Antifungal
   F. Antimalarial
   G. Antiprotozoal
   H. Antihelmintic
IX. Drugs affecting the musculoskeletal systems
   A. Anti-inflammatory
   B. Antispasmodic/muscle relaxants
   C. Anti-rheumatoid
   D. Anti gout
   E. Herbs/supplements
X. Drugs affecting eyes and ears
   A. Ophthalmic
   B. Otic
XI. Drugs affecting the body`s defense system
   A. Immunostimulant agents
   B. Immunosuppressant agents
   C. Colony stimulating factors
   D. Herbs/supplements
 
MCCCD Governing Board Approval Date: 5/27/2008

All information published is subject to change without notice. Every effort has been made to ensure the accuracy of information presented, but based on the dynamic nature of the curricular process, course and program information is subject to change in order to reflect the most current information available.